Physician profile
Nancy Concio
NPI 1568185809
$3,416.21
in general payments reported to CMS, 2019-2025
21 companies · $1,695 in 2025
The $1,695 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $61.84 · 2023: $544 · 2024: $1,115 · 2025: $1,695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,354.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,136.47 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals Lp | $479.00 | 2024-2025 | Airsupra, Breztri |
| Abbvie INC. | $256.25 | 2023-2025 | |
| Lilly USA, LLC | $247.10 | 2023-2025 | Mounjaro, Zepbound |
| Grifols USA, LLC | $212.07 | 2024-2025 | Prolastin-C Liquid |
| Verona Pharma, INC. | $146.62 | 2025 | Ohtuvayre |
| Inspire Medical Systems, INC. | $145.98 | 2024-2025 | Inspire |
| Aimmune Therapeutics, INC. | $125.00 | 2025 | Zenpep |
| Gilead Sciences, INC. | $124.54 | 2024 | |
| Amgen INC. | $124.54 | 2024 | Otezla |
| Glaxosmithkline, LLC. | $96.65 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Viatris Specialty LLC | $63.92 | 2025 | Yupelri |
| Janssen Scientific Affairs, LLC | $61.84 | 2022 | |
| Mylan Specialty L.P. | $31.57 | 2023 | Yupelri |
| Idorsia Pharmaceuticals US INC | $27.81 | 2023 | Quviviq |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.40 | 2023-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $26.16 | 2024 | Spravato |
| Exact Sciences Corporation | $24.12 | 2024 | Cologuard Collection Kit |
| Cequr Corporation | $23.00 | 2023 | Cequr Simplicity |
| Dexcom, INC. | $20.36 | 2025 | Dexcom G6 Transmitter |
| Renalytix Ai, INC. | $15.81 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Concio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.